Retrobulbar/intraconal tube placement in patients with glaucoma: Ahmed FP-7 and tube extender case series with 1 year follow-up. [PDF]
Laroche D, Grodecki B, Grimes KR, Ng C.
europepmc +1 more source
Pharmacogenetic Influences on Individual Responses to Ocular Hypotensive Agents in Glaucoma Patients. [PDF]
Labay-Tejado S+7 more
europepmc +1 more source
Evaluation of the Effect of Topical Prostaglandin Analog Treatment on Orbital Structures in Open-Angle Glaucoma with Computed Tomography. [PDF]
Durmuş Ece BŞ+4 more
europepmc +1 more source
Real-Life Study on the Efficacy and Tolerance of a Preservative-Free Surfactant-Free Latanoprost Eye Drop in Patients with Glaucoma. [PDF]
Chauchat L+4 more
europepmc +1 more source
Erratum: Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma. [PDF]
Editorial Office.
europepmc +1 more source
A phase III, multicentre, randomised, investigator-masked, cross-over, comparative, non-inferiority trial evaluating the efficacy and tolerability of generic preservative-free Latanoprost (Polpharma S.A.) compared to Xalatan® (Pfizer) in patients with ocular hypertension or primary open-angle glaucoma. [PDF]
Czumbel N+5 more
europepmc +1 more source
Advancements and Prospects in Nanorobotic Applications for Ophthalmic Therapy. [PDF]
Menezes Ferreira AÁ+4 more
europepmc +1 more source
Subconjunctival Administration of an Adeno-Associated Virus Expressing Stanniocalcin-1 Provides Sustained Intraocular Pressure Reduction in Mice. [PDF]
Roddy GW+8 more
europepmc +1 more source
Ahmed glaucoma valve implantation in a case of volatile intraocular pressure and preoperative hypotony. [PDF]
Katsev B, Campagna G, Liu JC.
europepmc +1 more source